Clinical trial
Efficacy and Safety of Factor VIIa on Rebleeding After Surgery for Spontaneous…
NCT00128050 · Fondazione IRCCS Policlinico San Matteo di Pavia, Other · Completed
Key facts
| NCT number | NCT00128050 |
|---|---|
| Title | Efficacy and Safety of Factor VIIa on Rebleeding After Surgery for Spontaneous Intracerebral Hemorrhage (ICH) |
| Official title | Efficacy and Safety of Factor VIIa (Eptacog Alfa) on Rebleeding After Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage. A Randomized, Controlled, Open-Label, Investigator-Blinded Pilot Study |
| Acronym | PRE-SICH |
| Lead sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intracerebral Hemorrhage |
| Intervention type | Drug, Other |
| Interventions | rFactor VIIa (Eptacog alfa, NovoNordisk), rFVIIa, Sodiun chloride 0.9% |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 9, 2005 |
| Last update posted | Feb 4, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: